Action of interleukin-2 and interleukin-4 on CRF mRNA in the hypothalamus and POMC mRNA in the anterior pituitary

Brain Behav Immun. 1992 Sep;6(3):214-22. doi: 10.1016/0889-1591(92)90044-o.

Abstract

We have used the technique of in situ hybridization histochemistry to determine corticotropin-releasing factor (CRF) mRNA in the hypothalamic paraventricular nucleus (PVN) and proopiomelanocortin (POMC) mRNA in the anterior pituitary of rats given a single ip injection of either interleukin (IL)-2 or IL-4. IL-2 increased POMC mRNA in the anterior pituitary in a dose-dependent manner. The effect was apparent both at 4 and 24 h after injection. No effect of IL-2 on CRF mRNA in the PVN was detected in these animals, suggesting that the increase in POMC mRNA was not driven by an increase in CRF. IL-4 was without effect at the hypothalamic level although this cytokine did result in a decrease in POMC mRNA in the anterior pituitary.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Corticotropin-Releasing Hormone / biosynthesis*
  • Hypothalamus / drug effects*
  • Hypothalamus / metabolism
  • Interleukin-2 / pharmacology*
  • Interleukin-4 / pharmacology*
  • Male
  • Pituitary Gland, Anterior / drug effects*
  • Pituitary Gland, Anterior / metabolism
  • Pro-Opiomelanocortin / biosynthesis*
  • RNA, Messenger / analysis
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Interleukin-2
  • RNA, Messenger
  • Interleukin-4
  • Pro-Opiomelanocortin
  • Corticotropin-Releasing Hormone